Daniel le, MD
Interventional Pain Medicine · Orange, CANPI 1902828569
Payments from drug & device makers
Across 60 payments — averaging $71.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Micromed Inc$357
- Abbott$339
- Forte Bio-pharma LLC$250
- Pacira Therapeutics, Inc.$223
- AbbVie$178
- plus $1K from 19 others
What the payments were for
- Travel & lodging$3578%
- Food & beverage$2,06048%
- Education$1,88344%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 4 | $1,948 |
| Micromed Inc | 2 | $357 |
| Abbott | 6 | $339 |
| Forte Bio-pharma LLC | 4 | $250 |
| Pacira Therapeutics, Inc. | 8 | $223 |
| AbbVie | 3 | $178 |
| Globus Medical | 2 | $153 |
| Stimwave Technologies Incorporated | 1 | $145 |
| Bioventus LLC | 5 | $113 |
| Nalu Medical, Inc. | 1 | $98 |
| Nevro Corp. | 4 | $97 |
| Saluda Medical Americas, Inc. | 3 | $93 |
| IBSA Pharma Inc. | 3 | $45 |
| Shionogi Inc | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Painteq LLC | 1 | $27 |
| Johnson & Johnson | 1 | $26 |
| Si-bone, Inc. | 1 | $25 |
| Mannkind Corporation | 1 | $20 |
| Radius Health, Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Pfizer | 1 | $14 |
| Amphastar Pharmaceuticals, Inc. | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| SPR Therapeutics, Inc | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolate$626
- Nalocet$232
- Senza$145
- CFNS StimQ Peripheral Nerve StimulatorSystem$145
- SCS FreedonSpinal Cord Stimulator$145
- PROCLAIM$145
- Skyrizi$122
How this compares
$4,300 in reported general payments places this provider in the 55th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 285 | $7,482 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 147 | $5,377 |
| MovantikNaloxegol Oxalate | 12 | $4,832 |
| Lidocaine | 26 | $4,133 |
| OxycontinOxycodone Hcl | 12 | $3,531 |
| Morphine Sulfate ErMorphine Sulfate | 71 | $2,119 |
| Oxycodone Hcl | 122 | $1,809 |
| Pregabalin | 96 | $1,514 |
| Gabapentin | 123 | $1,486 |
| Fentanyl | 18 | $1,227 |
| Zolpidem Tartrate ErZolpidem Tartrate | 12 | $1,219 |
| Tramadol Hcl | 89 | $712 |
| Tizanidine Hcl | 45 | $500 |
| Methocarbamol | 33 | $272 |
| Desipramine Hcl | 12 | $105 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Orange
- Standiford HelmOrange$476K
- Sheldon JordanSanta Monica$3.1M
- Ezekiel FinkBeverly Hills$2.3M
- Matthew DotyOroville$1.3M
- Tim LeierRancho Mirage$749K
- Pragya GuptaEscondido$647K
- Michael Verdolinla Mesa$563K
- Patrick BuchananCamarillo$453K
- Roy BrownlowSan Diego$452K
- Andrew GermanovichRancho Mirage$408K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.